This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures

Moderna Secures Contract with European Union for COVID-19 Vaccines

Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 Vaccine

Industry News

Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy

BARDA Funds Development of Patch-Based Ebola Diagnostic

RedHill Biopharma Highlights Federal Medical Countermeasure Investments

Airborne Biothreat Security Startup Raises $5.4M

BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection

Cue Health Awarded $28M to Develop Multiplex Respiratory Test

BD Respiratory Viral Panel Receives FDA-Clearance

BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions

After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure

Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX

VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders

DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing

Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19

FebriDx Rapid Diagnostic Receives FDA Clearance

A-Alpha Bio and Lawrence Livermore to Accelerate Antibody Discovery and Development for Biothreats

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

Biodefense Headlines – 31 March 2025

Assessing Research Security Efforts in Higher Education

International Pandemic Sciences Conference 2025